Marchese A, Docherty JM, Nguyen T, Heiber M, Cheng R, Heng HH, et al. (October 1994). "Cloning of human genes encoding novel G protein-coupled receptors". Genomics. 23 (3): 609–618. doi:10.1006/geno.1994.1549. PMID7851889.
Iismaa TP, Kiefer J, Liu ML, Baker E, Sutherland GR, Shine J (November 1994). "Isolation and chromosomal localization of a novel human G-protein-coupled receptor (GPR3) expressed predominantly in the central nervous system". Genomics. 24 (2): 391–394. doi:10.1006/geno.1994.1635. PMID7698767.
Zhang B, Ding J, Li Y, Wang J, Zhao Y, Wang W, et al. (May 2012). "The porcine Gpr3 gene: molecular cloning, characterization and expression level in tissues and cumulus-oocyte complexes during in vitro maturation". Molecular Biology Reports. 39 (5): 5831–5839. doi:10.1007/s11033-011-1393-y. PMID22207171. S2CID18513825.
Uhlenbrock K, Gassenhuber H, Kostenis E (November 2002). "Sphingosine 1-phosphate is a ligand of the human gpr3, gpr6 and gpr12 family of constitutively active G protein-coupled receptors". Cellular Signalling. 14 (11): 941–953. doi:10.1016/S0898-6568(02)00041-4. PMID12220620.
Schultz RM, Montgomery RR, Belanoff JR (June 1983). "Regulation of mouse oocyte meiotic maturation: implication of a decrease in oocyte cAMP and protein dephosphorylation in commitment to resume meiosis". Developmental Biology. 97 (2): 264–273. doi:10.1016/0012-1606(83)90085-4. PMID6189752. S2CID25357679.
Huang Y, Skwarek-Maruszewska A, Horré K, Vandewyer E, Wolfs L, Snellinx A, et al. (October 2015). "Loss of GPR3 reduces the amyloid plaque burden and improves memory in Alzheimer's disease mouse models". Science Translational Medicine. 7 (309): 309ra164. doi:10.1126/scitranslmed.aab3492. PMID26468326. S2CID35831952.
Ye C, Zhang Z, Wang Z, Hua Q, Zhang R, Xie X (June 2014). "Identification of a novel small-molecule agonist for human G protein-coupled receptor 3". The Journal of Pharmacology and Experimental Therapeutics. 349 (3): 437–443. doi:10.1124/jpet.114.213082. PMID24633425. S2CID27137928.
Laun AS (2018). A study of GPR3, GPR6, of GPR12 as novel molecular targets for cannabidiol (M.S. thesis). University of Louisville. doi:10.18297/etd/2945.
Marchese A, Docherty JM, Nguyen T, Heiber M, Cheng R, Heng HH, et al. (October 1994). "Cloning of human genes encoding novel G protein-coupled receptors". Genomics. 23 (3): 609–618. doi:10.1006/geno.1994.1549. PMID7851889.
Iismaa TP, Kiefer J, Liu ML, Baker E, Sutherland GR, Shine J (November 1994). "Isolation and chromosomal localization of a novel human G-protein-coupled receptor (GPR3) expressed predominantly in the central nervous system". Genomics. 24 (2): 391–394. doi:10.1006/geno.1994.1635. PMID7698767.
Zhang B, Ding J, Li Y, Wang J, Zhao Y, Wang W, et al. (May 2012). "The porcine Gpr3 gene: molecular cloning, characterization and expression level in tissues and cumulus-oocyte complexes during in vitro maturation". Molecular Biology Reports. 39 (5): 5831–5839. doi:10.1007/s11033-011-1393-y. PMID22207171. S2CID18513825.
Uhlenbrock K, Gassenhuber H, Kostenis E (November 2002). "Sphingosine 1-phosphate is a ligand of the human gpr3, gpr6 and gpr12 family of constitutively active G protein-coupled receptors". Cellular Signalling. 14 (11): 941–953. doi:10.1016/S0898-6568(02)00041-4. PMID12220620.
Schultz RM, Montgomery RR, Belanoff JR (June 1983). "Regulation of mouse oocyte meiotic maturation: implication of a decrease in oocyte cAMP and protein dephosphorylation in commitment to resume meiosis". Developmental Biology. 97 (2): 264–273. doi:10.1016/0012-1606(83)90085-4. PMID6189752. S2CID25357679.
Huang Y, Skwarek-Maruszewska A, Horré K, Vandewyer E, Wolfs L, Snellinx A, et al. (October 2015). "Loss of GPR3 reduces the amyloid plaque burden and improves memory in Alzheimer's disease mouse models". Science Translational Medicine. 7 (309): 309ra164. doi:10.1126/scitranslmed.aab3492. PMID26468326. S2CID35831952.
Ye C, Zhang Z, Wang Z, Hua Q, Zhang R, Xie X (June 2014). "Identification of a novel small-molecule agonist for human G protein-coupled receptor 3". The Journal of Pharmacology and Experimental Therapeutics. 349 (3): 437–443. doi:10.1124/jpet.114.213082. PMID24633425. S2CID27137928.
ncbi.nlm.nih.gov
"Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
"Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
Zhang B, Ding J, Li Y, Wang J, Zhao Y, Wang W, et al. (May 2012). "The porcine Gpr3 gene: molecular cloning, characterization and expression level in tissues and cumulus-oocyte complexes during in vitro maturation". Molecular Biology Reports. 39 (5): 5831–5839. doi:10.1007/s11033-011-1393-y. PMID22207171. S2CID18513825.
Schultz RM, Montgomery RR, Belanoff JR (June 1983). "Regulation of mouse oocyte meiotic maturation: implication of a decrease in oocyte cAMP and protein dephosphorylation in commitment to resume meiosis". Developmental Biology. 97 (2): 264–273. doi:10.1016/0012-1606(83)90085-4. PMID6189752. S2CID25357679.
Huang Y, Skwarek-Maruszewska A, Horré K, Vandewyer E, Wolfs L, Snellinx A, et al. (October 2015). "Loss of GPR3 reduces the amyloid plaque burden and improves memory in Alzheimer's disease mouse models". Science Translational Medicine. 7 (309): 309ra164. doi:10.1126/scitranslmed.aab3492. PMID26468326. S2CID35831952.
Ye C, Zhang Z, Wang Z, Hua Q, Zhang R, Xie X (June 2014). "Identification of a novel small-molecule agonist for human G protein-coupled receptor 3". The Journal of Pharmacology and Experimental Therapeutics. 349 (3): 437–443. doi:10.1124/jpet.114.213082. PMID24633425. S2CID27137928.